6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... #candida #mucosal ... IDSA #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
accumulation of clinical ... Assessment • Clinical ... ↑ sIL-2R >2400 Ul ... Histoplasmosis, candidiasis ... Treatment: •
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
• A state of hyperinflammatory ... noncompliance • Clinical ... initiation Clinical ... unintentional weight loss, nausea ... Parvovirus B19 • Candida
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
histoplasmosis (>10 cases ... weeks or until clinically ... with ARV (see Table ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis Infection ... a person with infectious ... HIV-infected persons with clinical ... Please refer to the table ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... please refer to Table ... IDSA #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology